funded by the National Natural Science Foundation of China(31320103918 and 82104318);Key Research and Development Program of Jiangsu Province(BE2021644);the Jiangsu Innovative and Entrepreneurial Talent Programme(JSSCBS20211568);the Science and Technology Plan of Suzhou(SKJYD2021161 and SKY2022046);Key Project of Jiangsu Provincial Health Commission(zd2021050);the Project of State Key Laboratory of Radiation Medicine and Protection,Soochow University(GZK1202203);support of Jiangsu Institute of Nuclear Medicine for the ^(89)Zr-PET imaging in this study。
B7 homolog 3(B7-H3)has attracted much attention in glioblastoma(GBM)radioimmunotherapy(RIT)due to its abnormally high expression on tumor cells.In this study,we report that two specific humanized anti-human B7-H3 anti...
supported by National Science Fund for Distinguished Young Scholars(82225025);National Natural Science Foundation of China(21877049,32171296,32201166,82172088);Guangdong Natural Science Foundation(2020B1515120043);Guangdong Basic and Applied Basic Research Fund Project(No.2021A1515111027);K.C.Wong Education Foundation.
The therapeutic efficacy of radioimmunotherapy against triple negative breast cancer(TNBC)is largely limited by the complicated tumor microenvironment(TME)and its immunosuppressive state.Thus developing a strategy to ...
supported by funds fromtheNationalNatural Science Foundation of China(82030082);the Academic Promotion Program of Shandong First Medical University(2019ZL002);the Radiation Oncology Innovate Unit,Chinese Academy of Medical Sciences(2019RU071);Key Research and Development Project of Shandong Province of China(2021CXGC011102);Shandong Provincial Natural Science Foundation(ZR2021QH006);Beijing Bethune Charitable Foundation(flzh202118).
Dear Editor,Increasing numbers of studies have revealed the immunomodulating effects of radiotherapy when combined with immune checkpoint inhibitors,as radioimmunotherapy has proven to be a promising treatment[1].Radi...
National Natural Science Foundation of China,Grant/Award Numbers:22122407,12175162,32171403,12075164,31971319,21874097;National Key Research Program of China,Grant/Award Number:2018YFA0208800;Tang Scholar Program;Scientific Research Program for Young Talents of China National Nuclear Corporation and A Priority Academic Program Development of Jiangsu Higher Education Institutions。
Therapeutic vaccines,an exciting development in cancer immunotherapy,share the goal of priming of personalized antigen-specific T-cell response by precise antigen presentation of dendritic cells(DCs),but major obstacl...
the National Natural Science Foundation of China(Nos.32171382,U1932208 U2032134,and 31900986);the Project of State Key Laboratory of Radiation Medicine and Protection,Soochow University(No.GZK1202110);the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD).
Tumor-targeting attenuated Salmonella could induce certain antitumor therapeutic effect through its proliferation characteristic and the consequent activated immune response,while host defense cells represented by neu...
supported by the National Natural Science Foundation of China(Nos.21976167,U20A20384);the CAEP Innovation and Development Foundation(No.CX20200003);Nuclear Energy Development Project of State Administration of Science,Technology and Industry for National Defense(No.20201192–1);Key R&D Project of Sichuan Science and Technology Program(No.2020YFS0030);the Central Guidance for Local Science and Technology Development Projects(No.202138–03)。
Carbohydrate antigen 19–9(CA19–9)with multi epitopes relatively high expresses on colorectal cancer(CRC)cells,making it an attractive target for developing radioimmunotherapy(RIT)for CRC.The lutetium-177(^(177)Lu)la...
This work is supported by grants from startup supports of Soochow University and the Program for Jiangsu Specially Appointed Professors to C.W;This work is partly supported by Collaborative Innovation Center of Suzhou Nano Science&Technology,the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD),the 111 Project;This work was also supported by the National Natural Science Foundation of China(No.31900988);the Natural Science Foundation of Jiangsu Province(No.SBK2019040088);Jiangsu Province Six Talent Peaks Project(No.SWYY-110).
Radiotherapy(RT)is a widely used way for cancer treatment.However,the efficiency of RT may come with various challenges such as low specificity,limitation by resistance,high dose and so on.Nitric oxide(NO)is known a v...
Supported by(partially)a Grant-in-Aid for Scientific Research(C)from the Ministry of Education,Culture,Sports,Science and Technology,Japan,No.17K10460 to Aung W
AIM To investigate the therapeutic effect of combined integrin α6β4-targeted radioimmunotherapy(RIT) and PI3 K/m TOR inhibitor BEZ235 in a pancreatic cancer model.METHODS Phosphorylation of Akt, m TOR, the downstrea...
Objective: Estimation of activity accumulated in tumor and organs is very important in predicting the response of radiopharmaceuticals treatment. In this study, we synthesized ~77Lutetium (177Lu)-trastuzumabiron ox...
The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131(^131I), phosphorous-32(^32P), strontium-90(^90Sr), and yttrium-90(^90Y), have b...